Charles Schwab’s Insys Therapeutics, Inc. INSY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-136,167
Closed -$630K 3307
2019
Q1
$630K Sell
136,167
-9,160
-6% -$42.4K ﹤0.01% 2678
2018
Q4
$509K Sell
145,327
-6,429
-4% -$22.5K ﹤0.01% 2765
2018
Q3
$1.53M Buy
151,756
+25,421
+20% +$256K ﹤0.01% 2506
2018
Q2
$915K Buy
126,335
+31,840
+34% +$231K ﹤0.01% 2606
2018
Q1
$571K Buy
94,495
+2,925
+3% +$17.7K ﹤0.01% 2694
2017
Q4
$881K Sell
91,570
-13,242
-13% -$127K ﹤0.01% 2546
2017
Q3
$931K Buy
104,812
+24,869
+31% +$221K ﹤0.01% 2525
2017
Q2
$1.01M Buy
79,943
+475
+0.6% +$6.01K ﹤0.01% 2452
2017
Q1
$836K Buy
79,468
+4,275
+6% +$45K ﹤0.01% 2478
2016
Q4
$692K Buy
75,193
+3,850
+5% +$35.4K ﹤0.01% 2548
2016
Q3
$842K Sell
71,343
-4,776
-6% -$56.4K ﹤0.01% 2448
2016
Q2
$985K Sell
76,119
-98,129
-56% -$1.27M ﹤0.01% 2351
2016
Q1
$2.79M Buy
174,248
+1,578
+0.9% +$25.2K ﹤0.01% 1878
2015
Q4
$4.94M Buy
172,670
+96,900
+128% +$2.77M 0.01% 1525
2015
Q3
$2.16M Buy
75,770
+15,381
+25% +$438K ﹤0.01% 2025
2015
Q2
$2.17M Buy
60,389
+6,011
+11% +$216K ﹤0.01% 2036
2015
Q1
$1.58M Buy
54,378
+7,614
+16% +$221K ﹤0.01% 2178
2014
Q4
$986K Buy
46,764
+1,220
+3% +$25.7K ﹤0.01% 2354
2014
Q3
$884K Buy
45,544
+16,144
+55% +$313K ﹤0.01% 2359
2014
Q2
$460K Sell
29,400
-34,830
-54% -$545K ﹤0.01% 2660
2014
Q1
$1.33M Buy
64,230
+42,630
+197% +$883K ﹤0.01% 2147
2013
Q4
$279K Hold
21,600
﹤0.01% 2837
2013
Q3
$263K Buy
+21,600
New +$263K ﹤0.01% 2811